Merck & Co., Inc. Licenses Ariadne Genomics' MedScan(TM) Text-to Knowledge Suite
Advertisement
Ariadne Genomics, Inc. announced that it has granted Merck & Co., Inc. of Whitehouse Station, New Jersey, a corporate-wide license for MedScan(TM) Text-to-Knowledge Suite software, Ariadne's automated scientific text processing tool. MedScan extracts information from text using state-of-the-art natural language processing (NLP) technology and converts scientific text into a database of protein functional relationships.
MedScan Text-to-Knowledge Suite software automatically extracts pathway-related information from text. Data regarding regulation, expression regulation, binding, molecular transport, protein modification, molecular synthesis etc. are recognized in the text and stored in XML files.